Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06845488 · ClinicalTrials.gov registry record · NA

Application of Virtual Reality Technology to Treatment of Social Anxiety

A NA study of Autism Spectrum Disorder and Social Anxiety Disorder, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06845488: Recruiting NA study of Autism Spectrum Disorder and Social Anxiety Disorder, sponsored by The University of Texas Health Science Center, Houston.

NCT06845488 is a NA study of Autism Spectrum Disorder and Social Anxiety Disorder that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 40 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06845488, a NA study of Autism Spectrum Disorder and Social Anxiety Disorder, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare CBT VR exposure + VR social skills treatment to CBT Imaginal exposure + mindfulness, in reducing the severity of social anxiety in adults with autism and social anxiety (SA), to identify characteristics associated with benefitting from the CBT-VR treatment and to assess acceptability and feasibility of the VR intervention for patients receiving it and use findings to improve methods and to prepare for a community based pragmatic trial.

Primary Outcome

This is a 24 item questionnaire, each is assessed in 2 ways measuring both fear/anxiety and avoidance related to specific social situations, giving a total of 48 ratings across the scale. The questions are scored from 0 (none) to 3 (severe) for a score range of 0-144 higher score indicating worse outcome.

Interventions

  • BEHAVIORAL CBT
  • DEVICE VR

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-11-07
Est. Completion 2026-03-31
Phase NA

What NCT06845488 shows while recruiting

NCT06845488 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (70% lower).

The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which CBT is the first listed.

NCT06845488 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06845488 about?

NCT06845488 is a clinical study titled "Application of Virtual Reality Technology to Treatment of Social Anxiety". The purpose of this study is to compare CBT VR exposure + VR social skills treatment to CBT Imaginal exposure + mindfulness, in reducing the severity of social anxiety in adults with autism and social anxiety (SA), to identify characteristics associated with benefitting from the CBT-VR treatment and...

What is the current status of trial NCT06845488?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-11-07. Estimated completion is 2026-03-31.

What conditions does trial NCT06845488 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Social Anxiety Disorder.

What interventions are being tested in trial NCT06845488?

The interventions under investigation include: CBT (BEHAVIORAL), VR (DEVICE).

Who is sponsoring clinical trial NCT06845488?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06845488 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06845488's enrollment target sits among peer trials

40 156th of 224 higher than 61 of 224 other Autism Spectrum Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06845488, the US trial registry maintained by the National Library of Medicine. NCT06845488 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.